All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other alimentary tract and metabolism products

Zavesca

(miglustat)

Uses, side effects, dosage information & price range

Janssen Cilag International NV

About this medicine

Zavesca is indicated for the oral treatment of adult patients with mild to moderate type-1 Gaucher disease. Zavesca may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. Zavesca is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick type-C disease.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

YargesaComposition: miglustatPiramal Critical Care B.V.
Price on RequestView Details →
Miglustat DipharmaComposition: miglustatDipharma Arzneimittel GmbH
Price on RequestView Details →
Miglustat Gen.OrphComposition: miglustatGen.Orph
Price on RequestView Details →
OpfoldaComposition: miglustatAmicus Therapeutics Europe Limited
Price on RequestView Details →

Key Information

Salt / Composition

miglustat

Category

Other alimentary tract and metabolism products

Manufacturer

Janssen Cilag International NV

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.